These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37577229)

  • 1. Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome.
    Li YJ; Wu XF; Wang DD; Li P; Liang H; Hu XY; Gan JQ; Sun YZ; Li JH; Li J; Shu X; Song AL; Yang CY; Yang ZY; Yu WF; Yang LQ; Wang XB; Belguise K; Xia ZY; Yi B
    J Clin Transl Hepatol; 2023 Oct; 11(5):1150-1160. PubMed ID: 37577229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice.
    Raevens S; Geerts A; Paridaens A; Lefere S; Verhelst X; Hoorens A; Van Dorpe J; Maes T; Bracke KR; Casteleyn C; Jonckx B; Horvatits T; Fuhrmann V; Van Vlierberghe H; Van Steenkiste C; Devisscher L; Colle I
    Hepatology; 2018 Aug; 68(2):634-651. PubMed ID: 29023811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
    Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
    J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
    Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
    Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
    Zhang J; Luo B; Tang L; Wang Y; Stockard CR; Kadish I; Van Groen T; Grizzle WE; Ponnazhagan S; Fallon MB
    Gastroenterology; 2009 Mar; 136(3):1070-80. PubMed ID: 19109954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
    Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD
    Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
    Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.
    Jayasena CN; Abbara A; Comninos AN; Narayanaswamy S; Gonzalez Maffe J; Izzi-Engbeaya C; Oldham J; Lee TT; Sarang Z; Malik Z; Dhanjal MK; Williamson C; Regan L; Bloom SR; Dhillo WS
    Hum Reprod; 2016 Dec; 31(12):2681-2688. PubMed ID: 27664209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
    Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
    Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markedly higher sFlt-1/PlGF ratio in a woman with acute fatty liver of pregnancy compared with HELLP syndrome.
    Suzuki H; Nagayama S; Hirashima C; Takahashi K; Takahashi H; Ogoyama M; Nagayama M; Shirasuna K; Matsubara S; Ohkuchi A
    J Obstet Gynaecol Res; 2019 Jan; 45(1):96-103. PubMed ID: 30141235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome.
    Cheng TY; Lee WS; Huang HC; Lee FY; Chang CC; Lin HC; Lee SD
    J Chin Med Assoc; 2017 Nov; 80(11):683-689. PubMed ID: 28969989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
    Matin M; Mörgelin M; Stetefeld J; Schermer B; Brinkkoetter PT; Benzing T; Koch M; Hagmann H
    Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.
    Gutman G; Barak V; Maslovitz S; Amit A; Lessing JB; Geva E
    Fertil Steril; 2008 Apr; 89(4):922-6. PubMed ID: 18343373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatopulmonary syndrome delays postoperative recovery and increases pulmonary complications after hepatectomy.
    Li YJ; Bai XH; Tang X; Yang ZY; Wang DD; Hu XY; Li P; Gu JT; Lu KZ; Belguise K; Wang XB; Yu WF; Yang LQ; Xia ZY; Yi B
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e449-e457. PubMed ID: 33852512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation.
    Tal R; Seifer DB; Grazi RV; Malter HE
    Reprod Biol Endocrinol; 2014 Aug; 12():82. PubMed ID: 25141961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.
    Wataganara T; Pratumvinit B; Lahfahroengron P; Pooliam J; Talungchit P; Leetheeragul J; Sukpanichnant S
    J Perinat Med; 2017 Oct; 45(7):895-901. PubMed ID: 28665791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Therapeutic Effects of Baicalein on the Hepatopulmonary Syndrome in the Rat Model of Chronic Common Bile Duct Ligation.
    Zeng Z; Lei Y; Yang C; Wu X; Zhang L; Yang Z; Chen L; Wang X; Belguise K; Li Y; Yi B
    J Clin Transl Hepatol; 2024 May; 12(5):496-504. PubMed ID: 38779522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.